Home/ISRN Endocrinology/Article Record
Peer-Reviewed Article March 6, 2012

Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: ISRN Endocrinology
Publisher: Hindawi Publishing Corporation • Egypt • 2090-4630
DOI: https://doi.org/10.5402/2012/816386

Abstract

Background. The most appropriate therapy for papillary microcarcinoma (PMC) is controversial. Methods. We reviewed the therapy and outcome of 407 patients with PMC. Results. Three hundred-eighty patients underwent total thyroidectomy, and 349 patients received I-131 therapy. The median followup was 5.3 years. Forty patients developed recurrent disease. On univariate analysis, development of disease recurrence was correlated with histological tumor size > 0.8 cm (P = 0.0104), age < 45 years (P = 0.043), and no I-131 therapy (P < 0.0001). On multivariate analysis, histological tumor size > 0.8 cm, positive lymph nodes, and no I-131 therapy were significant. The 5-year RFS for patients treated with I-131 was 95.0% versus 78.6% (P < 0.0001) for patients not treated with I-131. Patients with lymph node metastasis who did not receive I-131 had a 5-year RFS of 42.9% versus 93.2% (P < 0.0001) for patients who received I-131. Conclusions. Recommend I-131 remnant ablation for patients with PMC, particularly patients with lymph node metastasis.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

60
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.